Krop Julie bought DMAC
August 11, 2025 · Form 4 insider transaction
Krop Julie bought 450,000 shares of DiaMedica Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 84 days after the transaction.
Direction
Acquired (buy-side)
Shares
450,000
Price
$0.00
Total value
N/A
InsiderKrop Julie
RoleOfficer, Director
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateAugust 11, 2025
Filing dateNovember 3, 2025
Shares owned after450,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
112,500 shares vest on the one-year anniversary of the grant date, and the remaining 337,500 shares vest in twelve equal, or as nearly equal as possible, quarterly installments commencing three months after the one-year anniversary of the grant date; provided, however, that the participant remains continuously employed by or provides services to the Company, or one of its Subsidiaries or Affiliates, through the applicable vesting date.